Toripalimab: all 344 studies that test it
Page 2 of 4. Open to participants first (178), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal CancerNot yet recruitingNCT06283134Phase 1
- A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric CancerNot yet recruitingNCT06283121Phase 2
- Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal CarcinomaRecruitingNCT06277050Phase 3
- Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive ExpressionRecruitingNCT06269211Phase 2
- Toripalimab Combined With Definitive CCRT for LACC PatientsRecruitingNCT06256224Not applicable
- Adjuvant vs Surgery Only in Early-stage Recurrent NPCRecruitingNCT06228079Phase 3
- Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast CancerRecruitingNCT06227117Phase 2
- Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological TumorsNot yet recruitingNCT06221774Phase 1/2
- Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)RecruitingNCT06221670Phase 2
- A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With ChemotherapyRecruitingNCT06208826Phase 2
- FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind TrialRecruitingNCT06201065Phase 3
- Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)RecruitingNCT06187597Phase 2
- Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT06155383Phase 2
- Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLCRecruitingNCT06127303Phase 2
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)RecruitingNCT06095583Phase 3
- Induction Toripalimab and Chemotherapy in Locally Advanced Cervical CancerRecruitingNCT06093438Phase 1/2
- Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCCRecruitingNCT06081582Phase 2
- AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic CancerNot yet recruitingNCT06080854Phase 2
- 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial CancerRecruitingNCT06079112Phase 1/2
- Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung CancerRecruitingNCT06065813Phase 2
- A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid TumorsRecruitingNCT06038396Phase 1/2
- Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6RecruitingNCT06028672Not applicable
- GNT Induction Treatment in Locally Advanced NPCRecruitingNCT06026878Phase 3
- Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7RecruitingNCT06020755Phase 2
- Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal CarcinomaNot yet recruitingNCT05996484Phase 2
- RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBCRecruitingNCT05979740Phase 2
- Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaNot yet recruitingNCT05970627Phase 2
- Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal CancerRecruitingNCT05963490Phase 2
- Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR MutationNot yet recruitingNCT05962021Phase 2
- A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial CarcinomaRecruitingNCT05917158Phase 2
- Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaRecruitingNCT05907512Phase 2
- Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal CancerRecruitingNCT05877573Not applicable
- Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05861557Phase 2
- Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)Not yet recruitingNCT05842018Phase 2
- Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy StrategyRecruitingNCT05817201Phase 2/3
- Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical TherapyNot yet recruitingNCT05803915Phase 2
- Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLCRecruitingNCT05800340Phase 2
- Immunotherapy After Radiotherapy in Elderly ESCCNot yet recruitingNCT05791136Phase 2
- Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05773079Phase 2
- Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence FactorsRecruitingNCT05768464Phase 2
- Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaRecruitingNCT05738694Phase 3
- Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaRecruitingNCT05729646Phase 2
- A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI StatusRecruitingNCT05669092Phase 3
- Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICTRecruitingNCT05628922Phase 2
- Safety and Efficacy of RX-af01 Combined With PD-1 AntibodyRecruitingNCT05576961Phase 1/2
- Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable MelanomaNot yet recruitingNCT05539118Phase 1/2
- Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line TreatmentNot yet recruitingNCT05484375Phase 2
- Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive CarcinomaNot yet recruitingNCT05461235Phase 2
- Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal CarcinomaRecruitingNCT05420597Phase 2
- Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III StudyRecruitingNCT05342194Phase 3
- PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT05341193Phase 1/2
- Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III TrialRecruitingNCT05340491Phase 3
- A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder CancerRecruitingNCT05297552Phase 2
- JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal CarcinomaRecruitingNCT05173246Phase 2
- Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.Not yet recruitingNCT05162898Not applicable
- Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05147844Phase 2
- Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCCRecruitingNCT05125055Phase 2/3
- PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction CancerRecruitingNCT05033392Phase 2
- A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine CarcinomaRecruitingNCT05015621Phase 3
- Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer SubjectsRecruitingNCT04861584Phase 2
- Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant NeoplasmsNot yet recruitingNCT04825938Phase 2
- Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal CancerRecruitingNCT04819516Phase 1
- Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)RecruitingNCT04807140Phase 2
- Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT04778956Phase 3
- Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)Not yet recruitingNCT04772287Phase 3
- Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell CarcinomaNot yet recruitingNCT04716751Phase 2
- Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural MesotheliomaNot yet recruitingNCT04713761Phase 2
- Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRCRecruitingNCT04653480Phase 2
- Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCCNot yet recruitingNCT04624308Phase 2
- Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II StudyRecruitingNCT04462965Phase 2
- Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal CarcinomaNot yet recruitingNCT04447326Phase 2
- Toripalimab for Local-regional Recurrent Nasopharyngeal CarcinomaRecruitingNCT04376866Phase 3
- A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)RecruitingNCT04365036Phase 3
- Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)RecruitingNCT04278222Phase 2
- HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized TrialRecruitingNCT04135690Phase 2
- The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon CancerRecruitingNCT03985891Phase 1/2
- Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal CancerRecruitingNCT03926338Phase 2
- Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid TumorsRecruitingNCT03810339Phase 2
- Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell CarcinomaCompletedNCT03829969Phase 3Results posted
- The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal CancerCompletedNCT03581786Phase 3Results posted
- Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell CarcinomaActive, not recruitingNCT07047001Phase 2
- A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung CancerActive, not recruitingNCT06984588Phase 2/3
- Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLCWithdrawnNCT06732258Phase 1
- Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT06712888Phase 3
- Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)Active, not recruitingNCT06618014Phase 2
- A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal CancerActive, not recruitingNCT06584435Phase 2
- Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid TumorsActive, not recruitingNCT06571422Phase 1
- Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell LymphomaActive, not recruitingNCT06492629Phase 2
- Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid TumorsActive, not recruitingNCT06462222Phase 1/2
- Toripalimab for High-risk Locally Advanced Cervical CancerActive, not recruitingNCT06416696Phase 2
- TIP Regimen Combined With Toripalimab Neoadjuvant Therapy for Locally Advanced Penile CancerCompletedNCT06415318Phase 2
- A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)Active, not recruitingNCT06378177Phase 2
- Toripalimab Combined With SBRT for NSCLCActive, not recruitingNCT06293690Phase 2
- Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell CarcinomaActive, not recruitingNCT06279403Phase 2
- Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)TerminatedNCT06114940Phase 2
- Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast CancerWithdrawnNCT06105008Phase 2
- Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and ChemoradiationActive, not recruitingNCT05975307Phase 2
- Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLCActive, not recruitingNCT05888402Phase 2
- Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT05813626Phase 2
- Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRTStatus unknownNCT05763927Phase 2